Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

Authors

Liu C, Bayer A, Cosgrove SE, et al. 

Institution

Department of Medicine, Division of Infectious Diseases, University of California-San Francisco, San Francisco, California 94102, USA. catherine.liu@ucsf.edu

Source

Clin Infect Dis 2011 Feb 1; 52(3) :285-92.

Abstract

Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.

Mesh

Adolescent
Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents
Child
Child, Preschool
Humans
Infant
Infant, Newborn
Methicillin-Resistant Staphylococcus aureus
Middle Aged
Staphylococcal Infections
United States
Vancomycin
Young Adult

Language

eng

Pub Type(s)

Journal Article Practice Guideline Research Support, Non-U.S. Gov't

PubMed ID

21217178